An incurable disease
A new book explains how health care can become both more expensive and more affordable
HEALTH-CARE expenditure in America is growing at a disturbing rate: in 1960 it was just over 5% of GDP, in 2011 almost 18%. By 2105 the number could reach 60%, according to William Baumol of New York University’s Stern School of Business. Incredible? It is simply the result of extrapolating the impact of a phenomenon Mr Baumol has become famous for identifying: “cost disease”. His new book* gives a nuanced diagnosis, offerings both a vision of a high-cost future and a large dose of optimism. The cost disease may be incurable, but it is also survivable—if treated correctly.
This article appeared in the Finance & economics section of the print edition under the headline “An incurable disease”
More from Finance & economics
![](https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/media-assets/image/20240817_FNP002.jpg)
Europe’s economic growth is extremely fragile
Risk is concentrated in one country: Germany
![](https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/media-assets/image/20240817_FNP502.jpg)
How vulnerable is Israel to sanctions?
So far, measures have had little effect. That could change
![](https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/media-assets/image/20240817_FND000.jpg)
Why companies get inflation wrong
Bosses should pay less attention to the media
What is behind China’s perplexing bond-market intervention?
The central bank seems to think the government’s debt is too popular
How to invest in chaotic markets
Contrary to popular wisdom, even retail investors should pay attention to volatility
Vladimir Putin spends big—and sends Russia’s economy soaring
How long can the party last?